2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine

C101H112FN25O10 — CID 157101670

IUPAC2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine
SMILESCc1ccc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)c(F)c1.Cc1nnc(-c2ccc(NC3CCC(Oc4cc(N5CCOCC5)cc5nccnc45)CC3)nc2)o1.N#Cc1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cc(-c2ccc(NC3CCC(Oc4cc(N5CCOCC5)cc5nccnc45)CC3)nc2)[nH]n1
InChIInChI=1S/C26H29FN4O3.C26H29N7O3.C26H29N7O2.C23H25N7O2/c1-17-2-7-21(22(27)14-17)26(32)30-18-3-5-20(6-4-18)34-24-16-19(31-10-12-33-13-11-31)15-23-25(24)29-9-8-28-23;1-17-31-32-26(35-17)18-2-7-24(29-16-18)30-19-3-5-21(6-4-19)36-23-15-20(33-10-12-34-13-11-33)14-22-25(23)28-9-8-27-22;1-6-25(29-17-18(1)22-7-8-30-32-22)31-19-2-4-21(5-3-19)35-24-16-20(33-11-13-34-14-12-33)15-23-26(24)28-10-9-27-23;24-13-17-14-28-22(15-27-17)29-16-1-3-19(4-2-16)32-21-12-18(30-7-9-31-10-8-30)11-20-23(21)26-6-5-25-20/h2,7-9,14-16,18,20H,3-6,10-13H2,1H3,(H,30,32);2,7-9,14-16,19,21H,3-6,10-13H2,1H3,(H,29,30);1,6-10,15-17,19,21H,2-5,11-14H2,(H,29,31)(H,30,32);5-6,11-12,14-16,19H,1-4,7-10H2,(H,28,29)
InChIKeyAFVGYVBVPBMADT-UHFFFAOYSA-N
MW1855.17 g/mol
LogP15.04
Rot. Bonds22

About 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine

2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine (PubChem CID 157101670) has the molecular formula C101H112FN25O10 and a molecular weight of 1855.17 g/mol. Its IUPAC name is 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine.

Molecular Properties

Compound Name2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine
PubChem CID157101670
Molecular FormulaC101H112FN25O10
Molecular Weight1855.17 g/mol
Exact Mass1853.90
IUPAC Name2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine
SMILESCc1ccc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)c(F)c1.Cc1nnc(-c2ccc(NC3CCC(Oc4cc(N5CCOCC5)cc5nccnc45)CC3)nc2)o1.N#Cc1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cc(-c2ccc(NC3CCC(Oc4cc(N5CCOCC5)cc5nccnc45)CC3)nc2)[nH]n1
InChIInChI=1S/C26H29FN4O3.C26H29N7O3.C26H29N7O2.C23H25N7O2/c1-17-2-7-21(22(27)14-17)26(32)30-18-3-5-20(6-4-18)34-24-16-19(31-10-12-33-13-11-31)15-23-25(24)29-9-8-28-23;1-17-31-32-26(35-17)18-2-7-24(29-16-18)30-19-3-5-21(6-4-19)36-23-15-20(33-10-12-34-13-11-33)14-22-25(23)28-9-8-27-22;1-6-25(29-17-18(1)22-7-8-30-32-22)31-19-2-4-21(5-3-19)35-24-16-20(33-11-13-34-14-12-33)15-23-26(24)28-10-9-27-23;24-13-17-14-28-22(15-27-17)29-16-1-3-19(4-2-16)32-21-12-18(30-7-9-31-10-8-30)11-20-23(21)26-6-5-25-20/h2,7-9,14-16,18,20H,3-6,10-13H2,1H3,(H,30,32);2,7-9,14-16,19,21H,3-6,10-13H2,1H3,(H,29,30);1,6-10,15-17,19,21H,2-5,11-14H2,(H,29,31)(H,30,32);5-6,11-12,14-16,19H,1-4,7-10H2,(H,28,29)
InChIKeyAFVGYVBVPBMADT-UHFFFAOYSA-N
XLogP15.04
TPSA398.06 Ų
H-Bond Donors5
H-Bond Acceptors33
Rotatable Bonds22
Heavy Atoms137
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001855.17
LogP ≤ 515.04
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1033

Analyze 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine?
The IUPAC name of 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine (CID 157101670) is 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine.
What is the SMILES notation for 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine?
The canonical SMILES for 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine is Cc1ccc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)c(F)c1.Cc1nnc(-c2ccc(NC3CCC(Oc4cc(N5CCOCC5)cc5nccnc45)CC3)nc2)o1.N#Cc1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cc(-c2ccc(NC3CCC(Oc4cc(N5CCOCC5)cc5nccnc45)CC3)nc2)[nH]n1.
What is the InChIKey of 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine?
The InChIKey is AFVGYVBVPBMADT-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H29FN4O3.C26H29N7O3.C26H29N7O2.C23H25N7O2/c1-17-2-7-21(22(27)14-17)26(32)30-18-3-5-20(6-4-18)34-24-16-19(31-10-12-33-13-11-31)15-23-25(24)29-9-8-28-23;1-17-31-32-26(35-17)18-2-7-24(29-16-18)30-19-3-5-21(6-4-19)36-23-15-20(33-10-12-34-13-11-33)14-22-25(23)28-9-8-27-22;1-6-25(29-17-18(1)22-7-8-30-32-22)31-19-2-4-21(5-3-19)35-24-16-20(33-11-13-34-14-12-33)15-23-26(24)28-10-9-27-23;24-13-17-14-28-22(15-27-17)29-16-1-3-19(4-2-16)32-21-12-18(30-7-9-31-10-8-30)11-20-23(21)26-6-5-25-20/h2,7-9,14-16,18,20H,3-6,10-13H2,1H3,(H,30,32);2,7-9,14-16,19,21H,3-6,10-13H2,1H3,(H,29,30);1,6-10,15-17,19,21H,2-5,11-14H2,(H,29,31)(H,30,32);5-6,11-12,14-16,19H,1-4,7-10H2,(H,28,29).
What are the key properties of 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine?
2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine has a molecular weight of 1855.17 g/mol, XLogP of 15.04, 22 rotatable bonds, 5 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 2-fluoro-4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]benzamide;5-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrazine-2-carbonitrile;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(1H-pyrazol-5-yl)pyridin-2-amine is sourced from PubChem (CID 157101670), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).